News
Zacks Investment Research on MSN16h
Regeneron, SNY Report Mixed Results From Late-Stage COPD StudiesRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced mixed results from two late-stage studies, AERIFY-1 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback